BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma QC

Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis

Healthy volunteers phase completed showing differentiating target engagement biomarker data and favorable safety data On track for top-line histology da...

December 19, 2022 | News

Bio Elpida Acquisition Brings GMP Fill and Finish Capacity to Polyplus

“Bio Elpida is certified by the French Health Authorities (ANSM) as a Pharmaceutical Company to manufacture Active Pharmaceutical Ingredients and Adv...

December 15, 2022 | News

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that its European partner Angelini Pharma, an international pharmaceutical co...

December 09, 2022 | News

Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China

Thermo Fisher Scientific, the world leader in serving science, is opening a new facility in Hangzhou, China, as part of its global effort to help comp...

December 08, 2022 | News

GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering with Allozymes, a Singap...

December 07, 2022 | News

EMA Validates Application for Arpraziquantel to Treat Schistosomiasis in Preschool-Aged Children

Arpraziquantel is a potential new treatment option for the estimated 50 million preschool-aged children with schistosomiasis, one of the most devast...

December 06, 2022 | News

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea

-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...

November 28, 2022 | News

WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility

WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...

November 24, 2022 | News

AcuCort signs its first commercial agreement for the company's drug Zeqmelit™

Kamada Ltd., a leading global biopharmaceutical company, has a well-established infrastructure for marketing, sales, and distribution of commercial pharmac...

November 24, 2022 | News

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a Cellworks biosimulation...

November 23, 2022 | News

YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility from European Union GMP

YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commer...

November 16, 2022 | News

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

First mRNA manufacturing facility in Singapore will create regional manufacturing capacities in support of BioNTech’s growing pipeline of...

November 14, 2022 | News

SIRIO Launches Two Novel Gummies at CPHI Frankfurt

SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – launches two new gummies at&n...

October 20, 2022 | News

Bormioli Pharma reveals at CPHI Frankfurt new prototypes focusing on effective, patient-centered innovation

Bormioli Pharma, an international leader in the production of pharmaceutical packaging and medical devices, will attend at CPHI in Frankfurt (booth 30...

October 20, 2022 | News

Stay Connected